Toshima Y, Satoh S, Ikegaki I, Asano T
Laboratory for Pharmacology, Asahi Chemical Industry, Shizuoka, Japan.
Stroke. 2000 Sep;31(9):2245-50. doi: 10.1161/01.str.31.9.2245.
The aim of this study was to develop a new model of stroke based on endothelial damage and thrombotic occlusion in a perforating artery, leading to small cerebral infarcts and neurological deficits in rats. Moreover, the neuroprotective efficacy of fasudil, a rho-kinase inhibitor, was investigated in this model.
Fifty-six male Sprague-Dawley rats were used in the present study. Rats were anesthetized with sodium pentobarbital, and 100 microg of sodium laurate was injected into the left internal carotid artery on days 1 and 3. The thrombus induction and consequent of ischemic brain damage were examined by histopathological analyses and neurological deficit scoring in a posture reflex test. To investigate the neuroprotective effects of fasudil, 1 or 10 mg/kg was administered intraperitoneally 5 minutes after the first injection of sodium laurate and once daily thereafter on the following 2 days.
One hour after the injection of sodium laurate, microscopic examination of phosphotungstic acid hematoxylin-stained sections (n=5) revealed that microthrombi containing fibrin strands obstructed the perforating arteries in the ipsilateral hemisphere. Under a transmission electron microscope (n=6), endothelial cells appeared exfoliated and the vascular lumen was obstructed by a thrombus composed of degranulated platelets, fibrin, leukocytes, and erythrocytes. No evidence of endothelial cell damage or thrombus could be found in the ipsilateral side of the pial artery (middle cerebral artery). Twenty-four hours after the second injection of sodium laurate (day 4), 13 of 15 rats (86.6%) showed mild to severe neurological deficits. Multiple small cerebral infarcts were observed in the hippocampus, cortex, and thalamus. Treatment with fasudil (1 and 10 mg/kg, n=15 each) resulted in a significant improvement in neurological deficits. Fasudil also significantly reduced the area of cerebral infarction.
We present a new model of stroke in rats, in which the perforating arteries are selectively occluded by microthrombi. This model is useful to investigate the pathophysiology and treatment of small cerebral infarction, which is caused by perforating arterial occlusive diseases such as lacunar infarcts. Fasudil may be beneficial in the treatment of acute ischemic stroke.
本研究旨在基于穿支动脉内皮损伤和血栓形成闭塞构建一种新的脑卒中模型,该模型可导致大鼠发生小的脑梗死和神经功能缺损。此外,还在该模型中研究了Rho激酶抑制剂法舒地尔的神经保护作用。
本研究使用了56只雄性Sprague-Dawley大鼠。大鼠用戊巴比妥钠麻醉,在第1天和第3天向左侧颈内动脉注射100μg月桂酸钠。通过组织病理学分析和姿势反射试验中的神经功能缺损评分来检查血栓形成及随后的缺血性脑损伤情况。为研究法舒地尔的神经保护作用,在首次注射月桂酸钠后5分钟腹腔注射1或10mg/kg法舒地尔,此后连续2天每天注射1次。
注射月桂酸钠1小时后,对磷钨酸苏木精染色切片(n=5)进行显微镜检查发现,含有纤维蛋白丝的微血栓阻塞了同侧半球的穿支动脉。在透射电子显微镜下(n=6),内皮细胞出现脱落,血管腔被由脱颗粒血小板、纤维蛋白、白细胞和红细胞组成的血栓阻塞。在软脑膜动脉(大脑中动脉)同侧未发现内皮细胞损伤或血栓形成的迹象。第二次注射月桂酸钠后24小时(第4天),15只大鼠中有13只(86.6%)出现轻度至重度神经功能缺损。在海马、皮质和丘脑观察到多个小的脑梗死灶。用法舒地尔(1和10mg/kg,每组n=15)治疗可显著改善神经功能缺损。法舒地尔还显著减小了脑梗死面积。
我们提出了一种新的大鼠脑卒中模型,其中穿支动脉被微血栓选择性阻塞。该模型有助于研究由穿支动脉闭塞性疾病(如腔隙性梗死)引起的小的脑梗死的病理生理学和治疗方法。法舒地尔可能对急性缺血性脑卒中的治疗有益。